However, it has been suggested that viruses and chemicals may alter self-major histocompatibility structures such that T cells no longer recognize them as self (Gleichmann et al. 1976 ). This view has been supported by clinical and experimental evidence on the role of diphenylhydantoin in the production of autoimmune phenomena (Gleichmann et al. 1979) , and recently a patient has been reported with a syndrome resembling acute GVH disease where the trigger was thought to have been a drug or an infection (Breathnach et al. 1980) . Our patient's illness closely resembled chronic GVH disease yet she had not received a blood product transplant. There was no history of a viral infection preceding her illness. The only drug which she had taken prior to the onset of her symptoms was azapropazone, which has not previously been described in association with GVH-like reactions. Therefore we feel that our patients GVH-like disease was probably the result of alteration in self-antigens consequent upon her disseminated malignancy.
Our patient possessed the HLA antigens B8 and DR3. Batchelor (1980) has suggested that these antigens are markers of high immune responsiveness. In view of this it is possible that patients with B8 and DR3 would be more susceptible to the development of a GVH-Iike reaction on exposure to altered self-antigens.
This case lends support to the suggestion that GVH-like reactions are not simply limited to patients with bone marrow grafts or blood product transfusions but may develop in any situation in which there had been an alteration in self-antigens. Such a change in self-antigens could occur in malignant disease, certain viral infections or exposure to sensitizing drugs. This broader concept of GVH reactions may help us to advance our understanding of the pathogenesis of disorders such as lichen planus, coeliac disease and primary biliary cirrhosis which have overlapping features with GVH disease. Primary biliary cirrhosis is a multisystem disorder characterized by cholestatic jaundice and is often associated with other diseases such as Sjogren's syndrome or eRST. Its presentation as a protracted pyrexial illness without jaundice or pruritus does not appear to have been previously reported.
Case report
A 50-year-old Caucasian man presented in September 1981 with a three-week history of episodes of fever, rigors, night sweats and myalgia lasting 48 hours. Two months previously he had felt generally unwell and had lost 5 kg in weight. He had experienced similar but milder symptoms about twice a year for four years. A sister had Gaucher's disease but there was no other family history of note.
On examination he was pyrexial with no stigmata of chronic liver disease. There were no xanthelasma. The liver was enlarged 3 ern below the costal margin. Investigations showed Hb 14.5 g/dl, white cell count 7.9 x 10 9/dl, ESR 44 mm/h; electrolytes, creatine kinase, calcium and phosphate were all normal. Total protein was 'Case presented to Clinical Section, 12 November 1982. Accepted 17 February 1983 2Present address: London Chest Hospital, London E2 9JX 79 g/dl, globulin 37 g/dl, with normal electrophoretic strip. Bilirubin was 16 pmoljl, alanine transaminase 421Ujl, alkaline phosphatase 5791UjJ, and y-glutamyl transpeptidase 187 IUjl. Antinuclear factor was negative; rheumatoid factor was positive I: 128; smooth muscle antibodies positive I: 320; antimitochondrial antibodies I: 640; hepatitis B surface antigen negative. Multiple blood, urine and throat swab cultures were negative. Oral cholecystogram was normal. Ultrasound showed hepatomegaly and minimal splenomegaly. Liver biopsy showed changes of stage II primary biliary cirrhosis with florid bile duct destruction, with granuloma formation and heavy lymphocytic infiltration among markedly enlarged portal areas.
Following liver biopsy he developed breathlessness with fevers, rigors, atrial fibrillation and hypotension. Examination revealed fine, inspiratory crackles over both lung fields. Chest X-ray showed linear atelectasis at both bases and pulmonary function tests demonstrated a mild obstructive ventilatory defect with marked impairment of gas transfer. Rapid resolution of fever and symptoms was seen following prednisolone 60 mgjday. Clinical improvement and weight gain were accompanied by improvement in liver function tests. One month later alkaline phosphatase was 1361Ujl and y-GT 77 IUjl with normal bilirubin and alanine transaminase. After six months, with the patient well and with the dose of prednisolone reduced to 5 mg, liver biopsy was repeated. Following this he again developed fever with rigors and hypotension which responded to increasing steroid therapy. At present he remains well, taking a small maintenance dose of prednisolone. The liver is no longer palpable, and the biopsy showed no change.
Discussion
Primary biliary cirrhosis (PBq usually presents as pruritus and jaundice but may also manifest with hepatomegaly, portal hypertension or as a chance finding (Sherlock & Scheuer 1973) . Early diagnosis has been made in some patients with no hepatic symptoms who are being investigated for an associated condition such as CRST, Sjogren's syndrome or arthropathy (Long et al. 1977) . The mode of presentation may be changing, largely due to the increased detection rate of asymptomatic patients with abnormal liver function tests or antimitochrondrial antibodies (James et al. 1981) . We have been unable to find a description of a case of PBC presenting as a protracted pyrexial illness without jaundice or pruritus.
The clinical association between lung disease and primary biliary cirrhosis is controversial. In a study of 14 patients with PBC, the only consistently abnormal lung function finding was a reduction of gas transfer factor which was observed only in patients with PBC when associated with Sjogren's syndrome or sicca complex (Rodriguez-Roisin et al. 1981) . A marked decrease in gas transfer was observed in our patient. Whilst there were no symptoms of Sjogren's syndrome, the lung involvement seen in this patient together with the high titre of rheumatoid factor at presentation are suggestive of an underlying connective tissue disorder.
Corticosteroids are believed to produce no benefit in patients with PBC and it has been suggested that lack of response to steroid therapy is useful in differentiating between PBC and chronic active hepatitis (Guebel et al. 1976 ). However, following steroid therapy, our patient demonstrated an improvement in symptoms coupled with return of liver function towards normal. Repeat liver biopsy after six months showed no change. Workers at the Royal Free Hospital have reported two similar cases where immunosuppressive doses of prednisolone were used to treat two, fit, non-jaundiced patients with stage I disease (Thomas & Epstein 1981) . Follow-up liver biopsy showed a near normal liver in one patient and a marked improvement in another. Histological improvement was accompanied by return of liver function tests to normal. Withdrawal of steroids was accompanied by deterioration in liver function tests and biopsy appearances. Neither patient was febrile.
These findings in our patient and those of Thomas & Epstein (1981) cast doubt on the value of steroid therapy in differentiating between PBC and chronic active hepatitis, and our case lends support to the evidence that high-dose prednisolone given early in the disease to certain cases may induce a biochemical and histological remission.
